title: Reducing ischemia-reperfusion injury in clinical lung transplantation.
abstract: OBJECTIVE
  Acute graft dysfunction secondary to ischemia-reperfusion injury (IRI) continues to be the most common cause of early mortality after lung transplantation. The perioperative management with aprotinin could decrease the incidence of severe IRI.
  
  
  METHODS
  A retrospective analysis was conducted of the data from 180 patients who underwent either single lung (56%) or bilateral sequential lung transplantation for similar end-stage lung disease between 1997 and 2005. The most recent 68 patients were managed perioperatively with the high-dose aprotinin infusion regimen (aprotinin group). The ISHLT grade III injury score was used for the diagnosis of severe IRI, which is based on a Pao(2)-FIo(2) ratio of less than 200 mmHg.
  
  
  RESULTS
  Grade III injury was observed in 18% of the patients who were not managed with aprotinin (control group, 152 grafts, 64% single transplants, 68% male, 54 +/- 8 years of age). Early ECMO support was required in 25% of these patients. The associated mortality rate was 40%. Despite significantly longer cold ischemic times (290 +/- 14 minutes vs 231 +/- 14 minutes), older donors (42 +/- 12 years of age), and more frequently observed severely elevated systolic PAP of greater than 60 mmHg (60% vs 48%) as well as more frequently required extracorporeal circulatory support (24%* vs 12%) in the aprotinin group, the incidence of severe IRI (8%) and associated mortality (9%) was markedly reduced.
  
  
  CONCLUSIONS
  The use of aprotinin in LTX surgery, which had strong beneficial effects on patient outcomes, significantly decreased the incidence of severe posttransplant IRI.
authors.affiliation: Division of Thoracic and Cardiovascular Surgery, Heart Center Leipzig of the University of Leipzig, Leipzig, Germany. hartmuth.bittner@medizin.uni-leipzig.de
authors.forename: H B
authors.initials: HB
authors.lastname: Bittner
authors.forename: C
authors.initials: C
authors.lastname: Binner
authors.forename: P
authors.initials: P
authors.lastname: Dahlberg
authors.forename: F W
authors.initials: FW
authors.lastname: Mohr
mesh_terms: D000328:Adult; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D012042:Registries; D012086:Reoperation; D015427:Reperfusion Injury / Q000517:prevention & control*; D012189:Retrospective Studies